Sertaconazole nitrate is a broad-spectrum, synthetic, imidazole-derived antifungal agent. It is a second-generation azole antifungal with a benzothiophene moiety, which enhances its lipophilicity and tissue penetration. It exhibits potent fungistatic and fungicidal activity against dermatophytes, yeasts (including Candida albicans and non-albicans species), and Malassezia furfur. Its unique chemical structure provides additional anti-inflammatory and antipruritic properties, making it highly effective for treating cutaneous fungal infections with associated inflammation and itching, which are common presentations in the hot and humid Indian climate.
Adult: Apply a thin layer to cover the affected and surrounding area twice daily (morning and evening). For pityriasis versicolor, once daily application may be sufficient.
Note: 1. Wash and dry the affected area thoroughly. 2. Take a small amount of cream on a clean finger. 3. Apply a thin, even layer and gently rub in. 4. Wash hands after application (unless hands are being treated). 5. Continue use for the full prescribed time (typically 2-4 weeks), even if symptoms improve earlier, to prevent recurrence. For tinea pedis, apply between toes and on soles.
Sertaconazole inhibits the synthesis of ergosterol, an essential component of the fungal cell membrane. It acts by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This leads to accumulation of methylated sterol precursors and depletion of ergosterol, disrupting membrane structure and function, increasing permeability, and inhibiting fungal cell growth and replication.
Pregnancy: Category B (US FDA). Animal studies have shown no risk, but adequate and well-controlled studies in pregnant women are lacking. Due to minimal systemic absorption, topical use is generally considered safe during pregnancy when applied to limited areas. Use only if clearly needed and under medical supervision.
Driving: No effect on the ability to drive or operate machinery.
| Other topical medications (e.g., corticosteroids, retinoids) | Potential for increased irritation or altered absorption. Physically incompatible if mixed. | Moderate |
| Systemically administered Azole Antifungals (e.g., Fluconazole, Itraconazole) | Theoretical additive effect, but clinically significant interaction is unlikely due to minimal systemic levels of topical sertaconazole. | Low |